Literature DB >> 26155586

Peripheral Primitive Neuroectodermal Tumour of the Maxilla and Paranasal Sinuses: A Rare Clinical Presentation.

C L Krithika1, S Sathasivasubramanian2, C Ponranjini Vedeswari3.   

Abstract

Peripheral Primitive Neuroectodermal Tumours (pPNET) are rare aggressive tumours of neural crest cell origin. These tumours are more common in children and young adults. This is a unique report of one such presentation in a 23-year-old lady occurring in the left side posterior maxilla and Paranasal sinuses along with imaging characteristics, histopathologic features, immunohistochemical aspects and management. Though these tumours are rare, they should be considered in the differential diagnosis of rapidly growing soft tissue masses in young adults. Precise diagnosis with timely management is necessary for good prognosis.

Entities:  

Keywords:  Aggressive; Oral cavity; Small round cell tumours

Year:  2015        PMID: 26155586      PMCID: PMC4484178          DOI: 10.7860/JCDR/2015/13055.5949

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  5 in total

1.  Primitive neuroectodermal tumours: anatomic location, extent of surgery, and outcome.

Authors:  C Kimber; A Michalski; L Spitz; A Pierro
Journal:  J Pediatr Surg       Date:  1998-01       Impact factor: 2.545

Review 2.  How to treat the Ewing's family of sarcomas in adult patients.

Authors:  Michelle Scurr; Ian Judson
Journal:  Oncologist       Date:  2006-01

Review 3.  Primitive neuroectodermal tumor of the head and neck: incidence, diagnosis, and management.

Authors:  Jochen P Windfuhr
Journal:  Ann Otol Rhinol Laryngol       Date:  2004-07       Impact factor: 1.547

4.  Peripheral primitive neuroectodermal tumors of the head and neck.

Authors:  J E Jones; T McGill
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1995-12

5.  Primary pulmonary primitive neuroectodermal tumor metastasis to the pancreas: a rare case with seven-year follow-up.

Authors:  Lin Shi; Zhanlin Guo; Xinlin Wu
Journal:  Diagn Pathol       Date:  2013-03-27       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.